Jilin Province Huinan Changlong Bio-pharmacy Company Limited (08049.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 13Aug 18Aug 21Aug 26Aug 31Sep 3

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

0.5x

Market Cap

HKD 1.29B

MomentumView details →

1D Return

−1.50%

YTD Return

+5.50%

RSI (14)

44.4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

0.5x

Market Cap

HKD 1.29B

RSI (14)

44.4

MomentumView details →

1D Return

−1.50%

YTD Return

+5.50%

ProfitabilityView details →

Gross Margin

84.61%

Net Margin

25.09%

EBITDA Margin

33.97%

ROE (TTM)

15.38%

ROA (TTM)

10.19%

Asset Turnover

0.41x

GrowthView details →

Revenue YoY

+19.70%

EPS YoY

+53.46%

FCF YoY

—

Revenue CAGR 3Y

+2.33%

EPS CAGR 3Y

+0.00%

EBITDA YoY

+82.28%

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.00x

Current Ratio

1.47x

Quick Ratio

1.38x

Div Yield

12.52%

Div Rate

HKD 0.29

Div Growth 1Y

+5.27%

Financials snapshotView financials →

Revenue (TTM)

1.11B

Net Income (TTM)

278.44M

Op. CF (TTM)

0.00

Latest newsMore news →

No recent news for 08049.HK.

Similar companies

Essex Bio-Technology Limited01061.HK Cronos Group Inc.CRON Harrow Health, Inc.HROW Dawnrays Pharmaceutical (Holdings) Limited02348.HK JBM (Healthcare) Limited02161.HK Phibro Animal Health CorporationPAHC Find similar companies →

Latest newsMore news →

No recent news for 08049.HK.